These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8226814)

  • 1. Effect of heavy chain signal peptide mutations and NH2-terminal chain length on binding of anti-digoxin antibodies.
    Ping J; Schildbach JF; Shaw SY; Quertermous T; Novotny J; Bruccoleri R; Margolies MN
    J Biol Chem; 1993 Nov; 268(31):23000-7. PubMed ID: 8226814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spontaneous variant of an antidigoxin hybridoma antibody with increased affinity arises from a heavy chain signal peptide mutation.
    Shaw SY; Margolies MN
    Mol Immunol; 1992 Apr; 29(4):525-9. PubMed ID: 1565100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
    Schildbach JF; Shaw SY; Bruccoleri RE; Haber E; Herzenberg LA; Jager GC; Jeffrey PD; Panka DJ; Parks DR; Near RI
    Protein Sci; 1994 May; 3(5):737-49. PubMed ID: 8061604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an anti-digoxin antibody binding site by site-directed in vitro mutagenesis.
    Near RI; Mudgett-Hunter M; Novotny J; Bruccoleri R; Ng SC
    Mol Immunol; 1993 Mar; 30(4):369-77. PubMed ID: 8455637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
    Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
    J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regeneration of antidigoxin binding activity in an antibody by changes surrounding the original binding defect.
    Hudson NW; Albrecht M; Randhawa ZI; Steinrauf LK; Hamilton JA
    Mol Immunol; 1993 May; 30(7):685-93. PubMed ID: 8487784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
    Ruff-Jamison S; Glenney JR
    Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies.
    Near RI; Haber E
    Mol Immunol; 1989 Apr; 26(4):371-82. PubMed ID: 2497340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of antibody heavy chain CDR1 to digoxin binding analyzed by random mutagenesis of phage-displayed Fab 26-10.
    Short MK; Jeffrey PD; Kwong RF; Margolies MN
    J Biol Chem; 1995 Dec; 270(48):28541-50. PubMed ID: 7499368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features in the NH2-terminal region of a model eukaryotic signal peptide influence the site of its cleavage by signal peptidase.
    Nothwehr SF; Gordon JI
    J Biol Chem; 1990 Oct; 265(28):17202-8. PubMed ID: 2120214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI; Bruccoleri R; Novotny J; Hudson NW; White A; Mudgett-Hunter M
    J Immunol; 1991 Jan; 146(2):627-33. PubMed ID: 1898959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system.
    Wu XC; Ng SC; Near RI; Wong SL
    Biotechnology (N Y); 1993 Jan; 11(1):71-6. PubMed ID: 7763487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.
    Deng SJ; MacKenzie CR; Sadowska J; Michniewicz J; Young NM; Bundle DR; Narang SA
    J Biol Chem; 1994 Apr; 269(13):9533-8. PubMed ID: 8144539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display-selected sequences of the heavy-chain CDR3 loop of the anti-digoxin antibody 26-10 define a high affinity binding site for position 16-substituted analogs of digoxin.
    Krykbaev RA; Liu WR; Jeffrey PD; Margolies MN
    J Biol Chem; 2001 Mar; 276(11):8149-58. PubMed ID: 11060305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10.
    Schildbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Ng SC; Novotny J; Sheriff S; Margolies MN
    J Biol Chem; 1993 Oct; 268(29):21739-47. PubMed ID: 7691815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the combining site of an anti-carbohydrate antibody by saturation-mutagenesis: role of the heavy-chain CDR3 residues.
    Brummell DA; Sharma VP; Anand NN; Bilous D; Dubuc G; Michniewicz J; MacKenzie CR; Sadowska J; Sigurskjold BW; Sinnott B
    Biochemistry; 1993 Feb; 32(4):1180-7. PubMed ID: 8424945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
    J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding.
    de Haard HJ; Kazemier B; van der Bent A; Oudshoorn P; Boender P; van Gemen B; Arends JW; Hoogenboom HR
    Protein Eng; 1998 Dec; 11(12):1267-76. PubMed ID: 9930677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes.
    Near RI; Ng SC; Mudgett-Hunter M; Hudson NW; Margolies MN; Seidman JG; Haber E; Jacobson MA
    Mol Immunol; 1990 Sep; 27(9):901-9. PubMed ID: 2120577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
    Saini SS; Farrugia W; Ramsland PA; Kaushik AK
    Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.